Feline Hepatic Disease: Bile Acid Testing and Welfare Management
Bile acid testing helps identify hepatic disease in cats, guiding management of liver conditions that affect welfare through toxin accumulation and metabolic disruption.
Key Facts
- Bile acid stimulation testing assesses hepatic function and portal blood flow
- Portosystemic shunts in cats cause neurological signs from toxin accumulation (hepatic encephalopathy)
- Liver disease causes lethargy, weight loss, vomiting, and neurological signs
- Dietary management with hepatic-specific diets supports liver welfare
- Surgical treatment of portosystemic shunts can be curative in selected cats
Welfare Considerations
Hepatic disease welfare management requires addressing both the direct effects of liver dysfunction and the secondary effects of toxin accumulation. Cats with significant liver disease experience lethargy, anorexia, and nausea that reduce quality of life. Hepatic encephalopathy from portosystemic shunts causes neurological signs including behavioral changes, seizures, and altered consciousness that are distressing. Dietary management with restricted but high-quality protein reduces encephalopathy episodes. Lactulose and antibiotics reduce ammonia production in the gut. Surgical shunt ligation in appropriate candidates provides potential cure and dramatic welfare improvement.
What You Can Do
- Pursue accurate diagnosis with bile acid testing when liver disease is suspected
- Feed a hepatic-specific diet as prescribed by your veterinarian
- Administer lactulose and other hepatic supportive medications consistently
- Monitor for and manage hepatic encephalopathy episodes
- Discuss surgical treatment options with a specialist for portosystemic shunts